Andrew VarleyRNA & Formulation Core Director at The University of British ColumbiaSpeaker
Profile
Andrew Varley is Director of UBC's RNA & Formulation Core, where he leads manufacturing, analytical, and platform development efforts supporting next-generation RNA therapeutics. He established the facility and developed capabilities spanning mRNA, saRNA, and circRNA, enabling projects from early screening through large-animal studies while supporting dozens of external partners. Andrew supports global RNA therapeutics development as an Executive Committee member and Board Director of the Society for RNA Therapeutics and directs R&D initiatives focused on RNA manufacturing innovation, analytical characterization, and IVT process standards, including methods for detecting and controlling dsRNA impurities. His work accelerates translation from discovery to preclinical development.
Agenda Sessions
Circular RNA -The Next Frontier in RNA Therapeutics
, 12:10pmView SessionA Capillary Electrophoresis Approach to mRNA, saRNA, and circRNA Quality
, 2:30pmView Session
